相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Plasma Levels of Fetuin-A and Hepatic Enzymes and Risk of Type 2 Diabetes in Women in the U.S.
Qi Sun et al.
DIABETES (2013)
Mitochondrial dysfunction leads to impairment of insulin sensitivity and adiponectin secretion in adipocytes
Chih-Hao Wang et al.
FEBS JOURNAL (2013)
Pharmacological inhibition of adipocyte fatty acid binding protein alleviates both acute liver injury and non-alcoholic steatohepatitis in mice
Ruby L. C. Hoo et al.
JOURNAL OF HEPATOLOGY (2013)
Fibroblast Growth Factor-21 Regulates PPARγ Activity and the Antidiabetic Actions of Thiazolidinediones
Paul A. Dutchak et al.
CELL (2012)
Pathogenetic Mechanisms and Cardiovascular Risk Differences between HbA1c and oral glucose tolerance test for the diagnosis of glucose tolerance
Cristina Bianchi et al.
DIABETES CARE (2012)
Adiponectin Trajectories Before Type 2 Diabetes Diagnosis Whitehall II study
Adam G. Tabak et al.
DIABETES CARE (2012)
Prevalence of Prediabetes and Diabetes and Metabolic Profile of Patients With Nonalcoholic Fatty Liver Disease (NAFLD)
Carolina Ortiz-Lopez et al.
DIABETES CARE (2012)
Dorothy Hodgkin Lecture 2012 Non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management
C. D. Byrne
DIABETIC MEDICINE (2012)
TNF-α Represses β-Klotho Expression and Impairs FGF21 Action in Adipose Cells: Involvement of JNK1 in the FGF21 Pathway
Julieta Diaz-Delfin et al.
ENDOCRINOLOGY (2012)
How adiponectin, leptin, and ghrelin orchestrate together and correlate with the severity of nonalcoholic fatty liver disease
Mariana V. Machado et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2012)
Metformin Stimulates FGF21 Expression in Primary Hepatocytes
Eva B. Nygaard et al.
EXPERIMENTAL DIABETES RESEARCH (2012)
NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications
Geoffrey C. Farrell et al.
GUT AND LIVER (2012)
Effect of Nonalcoholic Fatty Liver Disease on the Development of Type 2 Diabetes in Nonobese, Nondiabetic Korean Men
Chang Wook Chon et al.
GUT AND LIVER (2012)
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
Naga Chalasani et al.
HEPATOLOGY (2012)
Metformin Regulates Glucose Transporter 4 (GLUT4) Translocation through AMP-activated Protein Kinase (AMPK)-mediated Cbl/CAP Signaling in 3T3-L1 Preadipocyte Cells
Jung Ok Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Relationship of Serum Fibroblast Growth Factor 21 with Abnormal Glucose Metabolism and Insulin Resistance: The Baltimore Longitudinal Study of Aging
Richard D. Semba et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
被撤回的出版物: Natural course of nonalcoholic fatty liver disease in southern China: A prospective cohort study (Retracted article. See vol. 23, pg. 350, 2022)
Yong Jian Zhou et al.
JOURNAL OF DIGESTIVE DISEASES (2012)
Combined Use of Serum Adiponectin and Tumor Necrosis Factor-Alpha Receptor 2 Levels Was Comparable to 2-Hour Post-Load Glucose in Diabetes Prediction
Yu-Cho Woo et al.
PLOS ONE (2012)
Liraglutide Increases FGF-21 Activity and Insulin Sensitivity in High Fat Diet and Adiponectin Knockdown Induced Insulin Resistance
Mengliu Yang et al.
PLOS ONE (2012)
Assessment and Treatment of Cardiovascular Risk in Prediabetes: Impaired Glucose Tolerance and Impaired Fasting Glucose
Ralph A. y DeFronzo et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Thiazolidinediones Are Potent Inducers of Fibroblast Growth Factor 21 Expression in the Liver
Katsutaka Oishi et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2011)
Selective Inactivation of c-Jun NH2-Terminal Kinase in Adipose Tissue Protects Against Diet-Induced Obesity and Improves Insulin Sensitivity in Both Liver and Skeletal Muscle in Mice
Xinmei Zhang et al.
DIABETES (2011)
High Plasma Level of Fibroblast Growth Factor 21 Is an Independent Predictor of Type 2 Diabetes A 5.4-year population-based prospective study in Chinese subjects
Cheng Chen et al.
DIABETES CARE (2011)
AMP-activated protein kinase is activated in adipose tissue of individuals with type 2 diabetes treated with metformin: a randomised glycaemia-controlled crossover study
J. G. Boyle et al.
DIABETOLOGIA (2011)
Sitagliptin as a Novel Treatment Agent for Non-Alcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus
Tomoyuki Iwasaki et al.
HEPATO-GASTROENTEROLOGY (2011)
Growth Hormone Induces Hepatic Production of Fibroblast Growth Factor 21 through a Mechanism Dependent on Lipolysis in Adipocytes
Wei Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Up-Regulation of PPAR-γ mRNA Expression in the Liver of Obese Patients: an Additional Reinforcing Lipogenic Mechanism to SREBP-1c Induction
Paulina Pettinelli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase
Shani Ben-Shlomo et al.
JOURNAL OF HEPATOLOGY (2011)
Serum adipocyte-specific fatty acid-binding protein is associated with nonalcoholic fatty liver disease in apparently healthy subjects
Young-Choon Kim et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2011)
Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis
Stergios A. Polyzos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Pioglitazone in the treatment of NASH: the role of adiponectin
A. Gastaldelli et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Kupffer Cell and Interleukin-12-Dependent Loss of Natural Killer T Cells in Hepatosteatosis
Michael Kremer et al.
HEPATOLOGY (2010)
Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis
Herbert Tilg et al.
HEPATOLOGY (2010)
Adipocyte Fatty Acid-binding Protein Modulates Inflammatory Responses in Macrophages through a Positive Feedback Loop Involving c-Jun NH2-terminal Kinases and Activator Protein-1
Xiaoyan Hui et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Elevated Fetuin-A Concentrations in Morbid Obesity Decrease after Dramatic Weight Loss
Johanna Maria Brix et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Rosiglitazone promotes fatty acyl CoA accumulation and excessive glycogen storage in livers of mice without adiponectin
Mingyan Zhou et al.
JOURNAL OF HEPATOLOGY (2010)
Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride
Huating Li et al.
JOURNAL OF HEPATOLOGY (2010)
Adiponectin and AdipoR1 regulate PGC-1α and mitochondria by Ca2+ and AMPK/SIRT1
Masato Iwabu et al.
NATURE (2010)
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
Giovanni Targher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Protective roles of adiponectin in obesity-related fatty liver diseases: mechanisms and therapeutic implications
Yu Wang et al.
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA (2009)
Adiponectin suppresses hepatic SREBP1c expression in an AdipoR1/LKB1/AMPK dependent pathway
Motoharu Awazawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity
M. Mraz et al.
CLINICAL ENDOCRINOLOGY (2009)
Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice
Jing Xu et al.
DIABETES (2009)
Circulating Fibroblast Growth Factor-21 Is Elevated in Impaired Glucose Tolerance and Type 2 Diabetes and Correlates With Muscle and Hepatic Insulin Resistance
Alberto O. Chavez et al.
DIABETES CARE (2009)
Selective Elevation of Adiponectin Production by the Natural Compounds Derived from a Medicinal Herb Alleviates Insulin Resistance and Glucose Intolerance in Obese Mice
Aimin Xu et al.
ENDOCRINOLOGY (2009)
Adipocyte Fatty Acid Binding Protein Levels Relate to Inflammation and Fibrosis in Nonalcoholic Fatty Liver Disease
Kerry-Lee Milner et al.
HEPATOLOGY (2009)
Low Serum Adiponectin Predicts 10-Year Risk of Type 2 Diabetes and HbA1c Independently of Obesity, Lipids, and Inflammation: Whitehall II Study
A. G. Tabak et al.
HORMONE AND METABOLIC RESEARCH (2009)
Low Serum Adiponectin Levels Are Predictive of Advanced Hepatic Fibrosis in Patients With NAFLD
Savvoula Savvidou et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2009)
Abnormal glucose tolerance in young male patients with nonalcoholic fatty liver disease
Jung Won Yun et al.
LIVER INTERNATIONAL (2009)
Final results of a long-term, clinical follow-up in fatty liver patients
Sanne Dam-Larsen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2009)
Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal
Naim Alkhouri et al.
Expert Review of Gastroenterology & Hepatology (2009)
Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans
Xinmei Zhang et al.
DIABETES (2008)
Serum Adipocyte Fatty Acid-Binding Protein Levels Are Associated With Nonalcoholic Fatty Liver Disease in Type 2 Diabetic Patients
J. Hyun Koh et al.
DIABETES CARE (2008)
Mitochondrial dysfunction contributes to the increased vulnerabilities of adiponectin knockout mice to liver injury
Mingyan Zhou et al.
HEPATOLOGY (2008)
Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets
Masato Furuhashi et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Adiponectin mediates the suppressive effect of rosiglitazone on plasminogen activator inhibitor-1 production
Ruby L. C. Hoo et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects
Jukka Westerbacka et al.
DIABETES (2007)
Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men
Michihiko Shibata et al.
DIABETES CARE (2007)
Nonalcoholic fatty liver disease
Leon A. Adams et al.
ANNALS OF EPIDEMIOLOGY (2007)
Serum adipocyte fatty acid-binding protein as a new biomarker, predicting the development of type 2 diabetes - A 10-year prospective study in a Chinese cohort
Annette W. K. Tso et al.
DIABETES CARE (2007)
Usefulness of a combined evaluation of the serum adiponectin level, HOMA-IR, and serum type IV collagen 7S level to predict the early stage of nonalcoholic steatohepatitis
Masahiko Shimada et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Effects of nonalcoholic fatty liver disease on the development of metabolic disorders
Jian-Gao Fan et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2
Masato Furuhashi et al.
NATURE (2007)
Hepatic fibroblast growth factor 21 is regulated by PPARα and is a key mediator of hepatic lipid metabolism in ketotic states
Michael K. Badman et al.
CELL METABOLISM (2007)
Role of adipocytokines in hepatic fibrogenesis
Kenichi Ikejima et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
The importance of metabolic factors for the increasing prevalence of fatty liver in Shanghai factory workers
Jian-Gao Fan et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome - A 5-year prospective study
Aimin Xu et al.
CIRCULATION (2007)
Prevalence and risk factors of fatty liver disease in the Shuiguohu district of Wuhan city, central China
Zhongli Wang et al.
POSTGRADUATE MEDICAL JOURNAL (2007)
The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21
Alexei Kharitonenkov et al.
ENDOCRINOLOGY (2007)
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Renata Belfort et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease
V. W. S. Wong et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Mattias Ekstedt et al.
HEPATOLOGY (2006)
Post-translational modifications of the four conserved lysine residues within the collagenous domain of adiponectin are required for the formation of its high molecular weight oligomeric complex
Yu Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease
G Tuncman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
α2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans
N Stefan et al.
DIABETES CARE (2006)
Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome
AM Xu et al.
CLINICAL CHEMISTRY (2006)
Peroxisome proliferator-activated receptor (PPAR)α activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue -: Comparison of activation of PPARα, PPAR-γ, and their combination
A Tsuchida et al.
DIABETES (2005)
Prevalence of and risk factors for fatty liver in a general population of Shanghai, China
JG Fan et al.
JOURNAL OF HEPATOLOGY (2005)
FGF-21 as a novel metabolic regulator
A Kharitonenkov et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms
E Bugianesi et al.
DIABETOLOGIA (2005)
Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes
K Maeda et al.
CELL METABOLISM (2005)
The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies
LA Adams et al.
JOURNAL OF HEPATOLOGY (2005)
Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity
UB Pajvani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes
Zobair M. Younossi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2004)
Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice
JB Boord et al.
CIRCULATION (2004)
Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity
JD Browning et al.
HEPATOLOGY (2004)
Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics
UJF Tietge et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
Adiponectin protects LPS-induced liver injury through modulation of TNF-α in KK-Ay obese mice
T Masaki et al.
HEPATOLOGY (2004)
Beyond insulin resistance in NASH:: TNF-α or adiponectin?
JM Hui et al.
HEPATOLOGY (2004)
The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice
AM Xu et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Adiponectin and protection against type 2 diabetes mellitus
J Spranger et al.
LANCET (2003)
A central role for JNK in obesity and insulin resistance
J Hirosumi et al.
NATURE (2002)
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
T Yamauchi et al.
NATURE MEDICINE (2002)
Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity - Interaction with family history of type 2 diabetes
M Stumvoll et al.
DIABETES (2002)
Metformin in non-alcoholic steatohepatitis
G Marchesini et al.
LANCET (2001)
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
AH Berg et al.
NATURE MEDICINE (2001)
Nonalcoholic fatty liver disease - A feature of the metabolic syndrome
G Marchesini et al.
DIABETES (2001)
The prevalence of diabetes, association with cardiovascular risk factors and implications of diagnostic criteria (ADA 1997 and WHO 1998) in a 1996 community-based population study in Hong Kong Chinese
ED Janus et al.
DIABETIC MEDICINE (2000)
Improved glucose and lipid metabolism in genetically obese mice lacking aP2
KT Uysal et al.
ENDOCRINOLOGY (2000)
分享论文
